• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, July 11, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Chinese FDA and IIVS re-affirm their collaboration for non-animal tests

Bioengineer by Bioengineer
September 7, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

GAITHERSBURG, MD – Sept. 7, 2017 – Bo Li, Director General Director of the CFDA's National Institute for Food and Drug Control (NIFDC) and Erin Hill, President of US based non-profit, Institute for In Vitro Sciences, Inc. (IIVS), signed a Memorandum of Understanding (MOU) to bring non-animal test methods to China for the regulation of cosmetics and ingredients. The move re-affirms and expands a three-year partnership between the NIFDC and IIVS.

Currently China has mandatory animal testing for many products, including special use and imported cosmetics. Wishing to modernize their regulations, CFDA has developed a plan to build capacity and proficiency within its government laboratories – key steps that the CFDA has stated must be achieved before regulations can be changed to incorporate non-animal tests for regulatory decision making. To date IIVS has helped NIFDC implement its plan by providing hands-on training, data interpretation workshops and other key elements to national and provincial government laboratories both in China and at its laboratory in the US. In November of 2016 the CFDA officially recognized the first non-animal test for cosmetics.

Under the new MOU, IIVS will continue to provide training, however, the two groups will now work together on other projects such as workshops with provincial IFDC leaders, many of whom are cosmetic safety reviewers, in an effort to build confidence in the new methods and thus accelerate their acceptance into the Chinese regulatory system.

###

About the Institute for In Vitro Sciences (IIVS)

IIVS is a non-profit organization wholly dedicated to the promotion of rapid and innovative non-animal test methods. Founded in 1997, IIVS is recognized as a leading provider of in vitro testing in support of toxicological safety evaluations. Rigorous scientific programs coupled with educational and outreach initiatives have established IIVS as a global leader in the advancement of alternatives to animal testing. For more information, visit us at http://www.iivs.org.

About the National Institute for Food and Drug Control (NIFDC)

NIFDC areas of responsibility cover quality control of pharmaceutical products, biological products, medical devices, food, healthy food, cosmetics, reference standards, laboratory animals, and drug safety evaluation. The Institute for Food and Cosmetics Control (IFCC), an internal institute of NIFDC, is responsible for safety evaluations of food, healthy food and cosmetics.

Media Contact

Laura Henning
[email protected]
240-454-8459
@the_iivs

Home

http://iivs.org/2017/09/07/chinese-fda-and-iivs-re-affirm-their-collaboration-for-non-animal-tests/

Share12Tweet8Share2ShareShareShare2

Related Posts

Han directs new $15M NIH center for organ-on-chip technology

Han directs new $15M NIH center for organ-on-chip technology

July 11, 2026
Bacteriophages Enable Next-Gen Smart Pathogen Detection Sensors

Bacteriophages Enable Next-Gen Smart Pathogen Detection Sensors

July 10, 2026

Temperature Fluctuations Have Greater Impact Than Previously Believed

July 10, 2026

New Study Uncovers Biology Behind Glioma Cancer Progression

July 10, 2026
Please login to join discussion

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Transient Simulation Advances in Bioresorbable Flexible Electronic Circuits

Evaluating Geriatric Assessment and Interventions for Prostate Cancer Patients on ADT

Single-Cell Multi-Omics Reveals Cancer-Associated Fibroblast Programs in Breast Cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.